摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(7-氯噻唑并[5,4-d]嘧啶-2-基)-对甲苯-胺 | 871266-80-7

中文名称
(7-氯噻唑并[5,4-d]嘧啶-2-基)-对甲苯-胺
中文别名
7-氯-N-(P-甲苯基)噻唑并[5,4-D]嘧啶-2-胺
英文名称
(7-chloro[1,3]thiazolo[5,4-d]pyrimidin-2-yl)(p-tolyl)amine
英文别名
2-(4-methylphenylamino)-7-chlorothiazolo[5,4-d]pyrimidine;(7-Chlorothiazolo[5,4-d]pyrimidin-2-yl)-p-tolyl-amine;7-chloro-N-(4-methylphenyl)-[1,3]thiazolo[5,4-d]pyrimidin-2-amine
(7-氯噻唑并[5,4-d]嘧啶-2-基)-对甲苯-胺化学式
CAS
871266-80-7
化学式
C12H9ClN4S
mdl
——
分子量
276.749
InChiKey
XJXOZVKBZZJUHT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    433.7±55.0 °C(Predicted)
  • 密度:
    1.480±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    78.9
  • 氢给体数:
    1
  • 氢受体数:
    5

安全信息

  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335

SDS

SDS:a9ab59f38a5292979da4f65db2bdcc04
查看

反应信息

  • 作为反应物:
    描述:
    (7-氯噻唑并[5,4-d]嘧啶-2-基)-对甲苯-胺L-脯氨醇甲醇 为溶剂, 以86%的产率得到2-(4-methylphenylamino)-7-[2(S)-hydroxymethylpyrrolidin-1-yl]thiazolo[5,4-d]pyrimidine
    参考文献:
    名称:
    Discovery of 7-(Prolinol-N-yl)-2-phenylamino-thiazolo[5,4-d]pyrimidines as Novel Non-Nucleoside Partial Agonists for the A2A Adenosine Receptor: Prediction from Molecular Modeling
    摘要:
    We describe the identification of 7-(prolinol-N-yl)-2-phenylamino-thiazolo[5,4-d]pyrimidines as a novel chemotype of non-nucleoside partial agonists for the A(2A) adenosine receptor (A(2A)AR). Molecular-modeling indicated that the (S)-2-hydroxymethylene-pyrrolidine could mimic the interactions of agonists' ribose, suggesting that this class of compounds could have agonistic properties. This was confirmed by functional assays on the A(2A)AR, where their efficacy could be associated with the presence of the 2-hydroxymethylene moiety. Additionally, the best compound displays promising affinity, selectivity profile, and physicochemical properties.
    DOI:
    10.1021/acs.jmedchem.6b00552
  • 作为产物:
    描述:
    4,6-二氯-5-氨基嘧啶对甲苯异硫氰酸酯 在 potassium fluoride on basic alumina 作用下, 以 乙腈 为溶剂, 反应 5.0h, 以90%的产率得到(7-氯噻唑并[5,4-d]嘧啶-2-基)-对甲苯-胺
    参考文献:
    名称:
    噻唑并[5,4- d ]嘧啶的合成,抗增殖和凋亡诱导活性
    摘要:
    噻唑并[5,4- d ]嘧啶是重要的一类具有多种生物活性的杂环化合物。在本文中,我们报告了使用可回收的KF /氧化铝催化剂高效合成噻唑并[5,4- d ]嘧啶的方法。4,6-二氯-5-氨基嘧啶在20 mol%KF /氧化铝存在下与异硫氰酸酯反应生成噻唑并[5,4- d]嘧啶类化合物,收率极高,无需任何色谱纯化。该方法操作简单,快速并且催化剂可以重复使用而没有任何明显的活性损失。在8种癌细胞系中测试了这些化合物的抗增殖活性,这些细胞系包括肺癌(NCI-H322和A549),表皮(A431),成胶质细胞瘤(T98G),胰腺(MIAPaCa-2),前列腺(PC-3),人白血病(HL-60)和乳腺癌(T47D)细胞。N,N'-二乙氨基取代的类似物2-(4-氯苯基氨基)-7-二乙氨基噻唑并[5,4- d ]嘧啶4k在肺(NCI-H322和A549),表皮(A431)中显示抗增殖活性和具有IC 50的
    DOI:
    10.1016/j.ejmech.2013.10.039
点击查看最新优质反应信息

文献信息

  • Synthesis, antiproliferative and apoptosis-inducing activity of thiazolo[5,4-d]pyrimidines
    作者:Baljinder Singh、Santosh K. Guru、Smit Kour、Shreyans K. Jain、Rajni Sharma、Parduman R. Sharma、Shashank K. Singh、Shashi Bhushan、Sandip B. Bharate、Ram A. Vishwakarma
    DOI:10.1016/j.ejmech.2013.10.039
    日期:2013.12
    Thiazolo[5,4-d]pyrimidines are important class of heterocyclic compounds possessing diverse range of biological activities. Herein, we report an efficient synthesis of thiazolo[5,4-d]pyrimidines using recyclable KF/alumina catalyst. The reaction of 4,6-dichloro-5-aminopyrimidine with isothiocyanates in presence of 20 mol% KF/alumina produced thiazolo[5,4-d]pyrimidines in excellent yields without any
    噻唑并[5,4- d ]嘧啶是重要的一类具有多种生物活性的杂环化合物。在本文中,我们报告了使用可回收的KF /氧化铝催化剂高效合成噻唑并[5,4- d ]嘧啶的方法。4,6-二氯-5-氨基嘧啶在20 mol%KF /氧化铝存在下与异硫氰酸酯反应生成噻唑并[5,4- d]嘧啶类化合物,收率极高,无需任何色谱纯化。该方法操作简单,快速并且催化剂可以重复使用而没有任何明显的活性损失。在8种癌细胞系中测试了这些化合物的抗增殖活性,这些细胞系包括肺癌(NCI-H322和A549),表皮(A431),成胶质细胞瘤(T98G),胰腺(MIAPaCa-2),前列腺(PC-3),人白血病(HL-60)和乳腺癌(T47D)细胞。N,N'-二乙氨基取代的类似物2-(4-氯苯基氨基)-7-二乙氨基噻唑并[5,4- d ]嘧啶4k在肺(NCI-H322和A549),表皮(A431)中显示抗增殖活性和具有IC 50的
  • Single-Step Syntheses of 2-Amino-7-chlorothiazolo[5,4-<i>d</i>]pyrimidines:  Intermediates for Bivalent Thiazolopyrimidines
    作者:Jian Liu、Raymond J. Patch、Carsten Schubert、Mark R. Player
    DOI:10.1021/jo0517702
    日期:2005.11.1
    A single-step process for the preparation of 2-amino-7-chlorothiazolo[5,4-d]pyrimidines, 2, was achieved by the reaction of the commercially available 4,6-dichloro-5-aminopyrimidine 1 with isothiocyanates. This mild reaction accommodates a variety of functionalized isothiocyanates and proceeds in good to excellent yields. The utility of such intermediates is exemplified by subsequent reaction with alkyl or arylamine nucleophiles to afford novel, differentially functionalized 2,7-diaminothiazolo[5,4-d]pyrimidines, 3.
  • Discovery of 7-(Prolinol-<i>N</i>-yl)-2-phenylamino-thiazolo[5,4-<i>d</i>]pyrimidines as Novel Non-Nucleoside Partial Agonists for the A<sub>2A</sub> Adenosine Receptor: Prediction from Molecular Modeling
    作者:Sandip B. Bharate、Baljinder Singh、Sonja Kachler、Ana Oliveira、Vikas Kumar、Sonali S. Bharate、Ram A. Vishwakarma、Karl-Norbert Klotz、Hugo Gutiérrez de Terán
    DOI:10.1021/acs.jmedchem.6b00552
    日期:2016.6.23
    We describe the identification of 7-(prolinol-N-yl)-2-phenylamino-thiazolo[5,4-d]pyrimidines as a novel chemotype of non-nucleoside partial agonists for the A(2A) adenosine receptor (A(2A)AR). Molecular-modeling indicated that the (S)-2-hydroxymethylene-pyrrolidine could mimic the interactions of agonists' ribose, suggesting that this class of compounds could have agonistic properties. This was confirmed by functional assays on the A(2A)AR, where their efficacy could be associated with the presence of the 2-hydroxymethylene moiety. Additionally, the best compound displays promising affinity, selectivity profile, and physicochemical properties.
查看更多

同类化合物

噻唑并[5,4-d]嘧啶-7(4H)-酮 噻唑并[5,4-d]嘧啶-5,7(4H,6H)-二酮 噻唑并[5,4-d]嘧啶-2(1H)-酮 噻唑并[5,4-d]嘧啶,5-氯- 噻唑[5,4-D]嘧啶-2-胺 叔丁基-(7-氯噻唑并[5,4-d]嘧啶-2-基)-胺 [1,3]噻唑并[5,4-D]嘧啶-7-胺 N7-丁基-n2-苯基噻唑并[5,4-d]嘧啶-2,7-二胺 N7-(4-甲氧基苯基)-n2-苯基噻唑并[5,4-d]嘧啶-2,7-二胺 N7-(3-氯苯基)-n2-苯基噻唑并[5,4-d]嘧啶-2,7-二胺 N2-苯基-n7-(3,4,5-三甲氧基苄基)噻唑并[5,4-d]嘧啶-2,7-二胺 N2,N7-二苯基-噻唑并[5,4-d]嘧啶-2,7-二胺 N-(7-氯-2-甲基噻唑并[5,4-D]嘧啶-5-基)新戊酰胺 7-氯噻唑并[5,4-D]嘧啶 7-氯-N-(邻甲苯基)噻唑并[5,4-D]嘧啶-2-胺 7-氯-5-甲基-[1,3]噻唑并[5,4-d]嘧啶 7-氯-5-(三氟甲基)[1,3]噻唑并[5,4-d]嘧啶 7-氨基-噻唑并[5,4-d]嘧啶-2(1H)-硫酮 7-(甲硫基)噻唑并[5,4-D]嘧啶-2-羧酸甲酯 5-甲硫基-9-硫杂-2,4,7-三氮杂双环[4.3.0]壬-2,4,7,10-四烯 5,7-二氯噻唑并[5,4-D]嘧啶 5,7-二氯-2-甲基-噻唑并[5,4-d]嘧啶 4-(5-氯噻唑并[5,4-D]嘧啶-7-基)吗啉 2-苯胺基[1,3]噻唑并[5,4-d]嘧啶-7-醇 2-苯基噻唑并[5,4-d]嘧啶-7-胺 2-甲基-4H-噻唑并[5,4-d]嘧啶-5,7-二酮 2-(甲基硫代)-噻唑并[5,4-d]嘧啶-7(4H)-酮 2,7-二氯噻唑并[5,4-D]嘧啶 2,5-二氯噻唑并[5,4-d]嘧啶 2,5-二氨基-6H-[1,3]噻唑并[4,5-e]嘧啶-7-酮 1-(7-氯噻唑并[5,4-d]嘧啶-2-基)-1,3-二甲基硫脲 1,3-二苄基-1-(7-氯噻唑并[5,4-d]嘧啶-2-基)硫脲 (7-氯噻唑并[5,4-d]嘧啶-2-基)苯胺 (7-氯噻唑并[5,4-d]嘧啶-2-基)异丙胺 (7-氯噻唑并[5,4-d]嘧啶-2-基)-对甲苯-胺 (7-氯噻唑并[5,4-d]嘧啶-2-基)-吡啶-3-基-胺 (7-氯噻唑并[5,4-d]嘧啶-2-基)-(4-甲氧基苯基)胺 (7-氯噻唑并[5,4-d]嘧啶-2-基)-(2,6-二甲基苯基)胺 (6CI,7CI,8CI,9CI)-噻唑并[5,4-d]嘧啶 ethyl 5-chlorothiazolo[5,4-d]pyrimidin-2-ylcarbamate N5-(3-fluorobenzyl)-2-(2-furanyl)[1,3]thiazolo[5,4-d]pyrimidine-5,7-diamine 2-methyl-N5-(thiophen-2ylmethyl)thiazolo[5,4-d]pyrimidine-5,7-diamine 2-(pyrazin-2-yl)-N5-(thiophen-2-ylmethyl)thiazolo[5,4-d]pyrimidine-5,7-diamine 2-(thiophen-2-yl)-N5-(thiophen-2-yl-methyl)[1,3]thiazolo[5,4-d]pyrimidine-5,7-diamine 2-phenyl-N5-(thiophen-2-ylmethyl)thiazolo[5,4-d]pyrimidine-5,7-diamine 2-(5-methylfuran-2-yl)-N5-(thiophen-2-yl-methyl)[1,3]thiazolo[5,4-d]pyrimidine-5,7-diamine 2-(furan-2-yl)-N5-(thiophen-2-yl-methyl)[1,3]thiazolo[5,4-d]pyrimidine-5,7-diamine (R)-N-benzyl-2-(5-ethyl-6-methyl-7-oxo-6,7-dihydro[1,3]thiazolo[5,4-d]pyrimidin-2-yl)pyrrolidine-1-carboxamide 2-(4-chlorophenylamino)-7-chlorothiazolo[5,4-d]pyrimidine 5-chlorothiazolo[5,4-d]pyrimidin-2-amine